Santa Cruz Biotechnology provides a broad selection of ALDH1 monoclonal antibodies for investigating aldehyde dehydrogenase 1 in various biological processes. ALDH1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Aldehyde dehydrogenase 1 is a critical enzyme involved in the detoxification of aldehydes and plays a significant role in cellular metabolism and stem cell biology. ALDH1 expression is often associated with cancer stem cells, making it an important target for cancer research and therapeutic development. Understanding ALDH1 function can provide insights into tumor progression and potential treatment strategies. ALDH1 research has revealed its importance in cellular defense mechanisms against oxidative stress. Recent studies have highlighted ALDH1's role in drug resistance and cancer cell survival. Ongoing research continues to uncover new functions of ALDH1 in development and disease. Santa Cruz Biotechnology monoclonal antibodies for ALDH1 support researchers worldwide in advancing our understanding of cancer biology and stem cell research.